Matek D, Matek I, Japjec M et al. · Pharmaceuticals (Basel, Switzerland) · PMID 41754849
From the original abstract
“Further clinical studies will strengthen cytoprotective therapy and, particularly, BPC 157 in complex musculoskeletal and junctional injuries.”
From the closing sentence of the indexed abstract. This is a short quotation from the authors, not a full study appraisal.
Read the full abstract & conclusionThis paper brings together existing research. Its conclusions depend on the included studies and their methods; it is not a separate treatment trial.
A brief excerpt cannot capture the complete methods, results, adverse events, or limitations. Check the full abstract and original paper before interpreting the finding.
Educational research information. A publication does not verify the identity, quality, or safety of products sold here.
Back to BPC-157 studies